Two clones, one niche: how CH shapes the MM microenvironment

Adam S Sperling^{1

2}

Affiliations

Editorial

Adam S Sperling. Blood. 2025.

. 2025 Jul 31;146(5):524-525.

doi: 10.1182/blood.2025029174.

Adam S Sperling^{1

2}

No abstract available

Conflict of interest statement

Conflict-of-interest disclosure: A.S.S. has received consulting fees from Novartis.

Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes.
Lionetti M, Scopetti M, Matera A, Maeda A, Marella A, Lazzaroni F, Castellano G, Fabris S, Pioggia S, Lonati S, Marchetti A, Cattaneo A, Tornese M, Neri A, Leoni C, Pettine L, Traini V, Silvestris I, Barbieri M, Fabbiano G, Ronchetti D, Taiana E, De Magistris C, Da Vià MC, Passamonti F, Bolli N. Lionetti M, et al. Blood. 2025 Jul 31;146(5):571-584. doi: 10.1182/blood.2024026236. Blood. 2025. PMID: 40112284

1. Lionetti M, Scopetti M, Matera A, et al. Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes. Blood. 2025;146(5):571–584. - PubMed
1. Jaiswal S. Clonal hematopoiesis and nonhematologic disorders. Blood. 2020;136(14):1606–1614. - PMC - PubMed
1. Gibson CJ, Lindsley RC, Tchekmedyian V, et al. Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma. J Clin Oncol. 2017;35(14):1598–1605. - PMC - PubMed
1. Mouhieddine TH, Sperling AS, Redd R, et al. Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant. Nat Commun. 2020;11(1):2996. - PMC - PubMed
1. Tahri S, Mouhieddine TH, Redd R, et al. Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenstrom macroglobulinemia. Blood Adv. 2022;6(7):2230–2235. - PMC - PubMed